A Brazilian volunteer in the AstraZeneca COVID-19 vaccine trial has died, health officials announced Wednesday.
The Brazil National Health Surveillance Agency (ANVISA) said it was notified Monday of the participant’s death and received data from the investigation into the matter.
The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in the country, also confirmed the death.
The patient wasn’t identified, but local media said he was a 28-year-old doctor in Rio de Janeiro who had been on the frontlines of the COVID-19 pandemic, Brazilian outlet Globo reported.
It’s unclear whether the volunteer had been among the participants who received the potential vaccine or a placebo.
ANVISA said testing of the vaccine developed by AstraZeneca with the University of Oxford in Britain would continue after the volunteer’s death.
The study previously faced a setback in September when one of the participants in the United Kingdom suffered an adverse reaction, prompting the company to temporarily pause the trials.
AstraZeneca didn’t immediately respond to request for comment.
By J.B. Sandlin (Chief Editor) The MSM can no longer hide the obvious truth from the publ ...November 30, 2020 Johns Hopkins University Newsletter Ran Study Saying COVID 'Relatively No Effect on Deaths' in U.S., Then Deleted It After Publication
By Nick Arama Earlier this week, Johns Hopkins University Newsletter ran a study fro ...November 28, 2020 Biden Will Be Most Sheltered, Least Seen President Since FDR
With Joe Biden now well on his way to moving into the White House on Jan. 20, 2021, Americ ...November 25, 2020